Hydrochlorthiazide

Hydrochlorthiazide

SCHEMBL2581931

CC(=O)O.c1cscn1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochlorthiazide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102919799-B Cream enzymolysis composition and preparation method thereof DADHANK CHENGDU BIOTECH CO LTD 2014-06-25 CN claimed
CN-102919799-A Cream enzymolysis composition and preparation method thereof DADHANK CHENGDU BIOTECH CO LTD 2013-02-13 CN claimed
CN-1492867-A Thiazoleacetic thioester derivatives and their use in the preparation of cephalosporin compounds �¿˵»�ѧҽҩƷ���޹�˾ 2004-04-28 CN claimed
EP-0477197-B1 PREPARATION OF 2-(2-TRITYLAMINOTHIAZOL-4-YL)-2-SYN-METHOXYIMINOACETIC ACID UPJOHN CO (US) 1995-07-12 EP claimed
CN-1073444-A Cephalosporin compound and preparation method thereof TANABE SEIYAKU CO (JP) 1993-06-23 CN claimed
EP-0477197-A1 PREPARATION OF 2-(2-TRITYLAMINOTHIAZOL-4-YL)-2-SYN-METHOXYIMINOACETIC ACID. UPJOHN CO (US) 1992-04-01 EP claimed
CN-1014321-B PROCESS FOR PRODUCING GLUTACONIC ACID DERIVATIVE SHIONOGI & CO (JP) 1991-10-16 CN claimed
WO-1990015802-A1 PREPARATION OF 2-(2-TRITYLAMINOTHIAZOL-4-YL)-2-SYN-METHOXYIMINOACETIC ACID THE UPJOHN COMPANY (US) 1990-12-27 WO claimed
EP-0318488-A4 STIMULATION OF ANGIOGENESIS AND PROMOTION OF ENDOTHELIALISATION. BIOTA SCIENT MANAGEMENT (AU) 1990-02-26 EP claimed
EP-0294380-A4 STIMULATION OF ANGIOGENESIS. BIOTA SCIENT MANAGEMENT (AU) 1990-02-20 EP claimed
EP-0318488-A1 STIMULATION OF ANGIOGENESIS AND PROMOTION OF ENDOTHELIALISATION BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. (AU) 1989-06-07 EP claimed
EP-0294380-A1 STIMULATION OF ANGIOGENESIS BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. (AU) 1988-12-14 EP claimed
WO-1988001166-A1 STIMULATION OF ANGIOGENESIS AND PROMOTION OF ENDOTHELIALISATION BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 1988-02-25 WO claimed
WO-1987004925-A1 STIMULATION OF ANGIOGENESIS BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. (AU) 1987-08-27 WO claimed
CN-85106433-A Produce the method for glutaconic acid derivative 1987-03-18 CN claimed
JP-9067354-A None JP disclosed
JP-9067353-A None JP disclosed
WO-1988001166-A1 STIMULATION OF ANGIOGENESIS AND PROMOTION OF ENDOTHELIALISATION BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 1988-02-25 WO disclosed
CN-85106433-A Produce the method for glutaconic acid derivative 1987-03-18 CN disclosed
CN-85106433-A Produce the method for glutaconic acid derivative 1987-03-18 CN disclosed